Experts call for increased neonatal inclusion in pediatric drug trials
Thursday, October 25, 2012 - 19:00
in Health & Medicine
Clinical drug trials are a vital part of pharmaceutical manufacturers gaining approval for use by the U.S. Food and Drug Administration. A new commentary assesses the issues surrounding the lack of clinical trials on medications used by children, most notably neonates, and how drug manufacturers and academic researchers could work together to create clinical trials that would benefit this underrepresented population.